Detecting resistance to docetaxel in breast cancer treatment

被引：0
|
作者：
Laffman-Johnson, Elise
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 84卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：646 / 646
页数：1
相关论文
共 50 条
  • [31] RPN2 gene confers docetaxel resistance in breast cancer
    Kimi Honma
    Kyoko Iwao-Koizumi
    Fumitaka Takeshita
    Yusuke Yamamoto
    Teruhiko Yoshida
    Kazuto Nishio
    Shunji Nagahara
    Kikuya Kato
    Takahiro Ochiya
    Nature Medicine, 2008, 14 : 939 - 948
  • [32] MicroRNA-452 contributes to the docetaxel resistance of breast cancer cells
    Hu, Qing
    Chen, Wei-xian
    Zhong, Shan-liang
    Zhang, Jun-ying
    Ma, Teng-fei
    Ji, Hao
    Lv, Meng-meng
    Tang, Jin-hai
    Zhao, Jian-hua
    TUMOR BIOLOGY, 2014, 35 (07) : 6327 - 6334
  • [33] INVOLVEMENT OF MiR-34A IN RESISTANCE OF BREAST CANCER CELLS TO DOCETAXEL
    Kastl, Lena
    Schofield, Andrew C.
    EJC SUPPLEMENTS, 2010, 8 (06): : 20 - 21
  • [34] RPN2 gene confers docetaxel resistance in breast cancer
    Honma, Kimi
    Iwao-Koizumi, Kyoko
    Takeshita, Fumitaka
    Yamamoto, Yusuke
    Yoshida, Teruhiko
    Nishio, Kazuto
    Nagahara, Shunji
    Kato, Kikuya
    Ochiya, Takahiro
    NATURE MEDICINE, 2008, 14 (09) : 939 - 948
  • [35] RPN2 overexpression confers resistance to docetaxel in breast cancer
    Nature Clinical Practice Oncology, 2008, 5 (12): : 686 - 686
  • [36] High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer
    Kim, SJ
    Miyoshi, Y
    Taguchi, T
    Tamaki, Y
    Nakamura, H
    Yodoi, J
    Kato, K
    Noguchi, S
    CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8425 - 8430
  • [37] Docetaxel is a potent cytotoxic drug in the treatment of advanced breast cancer
    Van Vaerenbergh, W
    Paridaens, R
    Thomas, J
    Wildiers, J
    Van Oosterom, A
    ACTA CLINICA BELGICA, 1998, 53 (04): : 264 - 269
  • [38] HIV Vif protein in docetaxel treatment of breast cancer cells
    Cipriano, Pedro
    Bandarra, Susana
    Goncalves, Joao
    Ribeiro, Ana Clara
    Barahona, Isabel
    ANNALS OF MEDICINE, 2021, 53 : S94 - S95
  • [39] Difference between brand and generic docetaxel in breast cancer treatment
    Salamoon, M.
    Alsaleh, Y.
    Jaafar, N.
    Bachour, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S468 - S468
  • [40] Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer
    Ravdin, PM
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 18 - 21
12345